XLO Message Board Post 10049816 | null
home / stock / xlo / xlo message board
Gobrogo47
(investorshub)
Posted on: Feb/10/2022 18:51:56
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=167841685
Xilio Therapeutics, Inc. is a biotechnology company. The
News, Short Squeeze, Breakout and More Instantly...
-
WALTHAM, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced the appointment of Aoife Brennan, M.D., and James Sh...
-
Expect to initiate Phase 2 trial for XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4, in combination with atezolizumab in patients with microsatellite stable colorectal cancer (MSS CRC) in the third quarter of 2024 Plan to report clinical data for XTX101 and XTX301, a tumor-a...